{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:44:25Z","timestamp":1792071865305,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Integrative Pharmacological Sciences Training Program"},{"name":"HFH + MSU Health Sciences"},{"name":"National Institute of Environmental Health Sciences of the National Institutes of Health","award":["R01ES030695"],"award-info":[{"award-number":["R01ES030695"]}]},{"name":"Michigan State University Startup Funds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15707-0","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:19:54Z","timestamp":1755677994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["GPT2 mediates glutamine metabolism-driven metabolic alterations in platinum-resistant ovarian cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Adriana","family":"Ponton-Almodovar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary P.","family":"Udumula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrinda","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandeep","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie J.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Horibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"15707_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA A Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21871 (2025).","journal-title":"CA A Cancer J. Clin."},{"key":"15707_CR2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21456","author":"LA Torre","year":"2018","unstructured":"Torre, L. A. et al. Ovarian cancer statistics, 2018. CA: Cancer J. Clin. https:\/\/doi.org\/10.3322\/caac.21456 (2018).","journal-title":"CA: Cancer J. Clin."},{"key":"15707_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1179299X19860815","author":"R Pokhriyal","year":"2019","unstructured":"Pokhriyal, R., Hariprasad, R., Kumar, L. & Hariprasad, G. Chemotherapy resistance in advanced ovarian cancer patients. Biomark. Cancer https:\/\/doi.org\/10.1177\/1179299X19860815 (2019).","journal-title":"Biomark. Cancer"},{"key":"15707_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010119","author":"G Damia","year":"2019","unstructured":"Damia, G. & Broggini, M. Platinum resistance in ovarian cancer: role of DNA repair. Cancers https:\/\/doi.org\/10.3390\/cancers11010119 (2019).","journal-title":"Cancers"},{"key":"15707_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100917","author":"RP Patel","year":"2021","unstructured":"Patel, R. P. et al. Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms. Transl. Oncol. https:\/\/doi.org\/10.1016\/j.tranon.2020.100917 (2021).","journal-title":"Transl. Oncol."},{"key":"15707_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.025","author":"S Dasari","year":"2014","unstructured":"Dasari, S. & Tchounwou, P. B. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"15707_CR7","first-page":"5713","volume":"48","author":"H Masuda","year":"1988","unstructured":"Masuda, H. et al. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res 48, 5713\u20135716 (1988).","journal-title":"Cancer Res"},{"key":"15707_CR8","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005637","author":"D-W Shen","year":"2012","unstructured":"Shen, D.-W., Pouliot, L. M., Hall, M. D. & Gottesman, M. M. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol. Rev. https:\/\/doi.org\/10.1124\/pr.111.005637 (2012).","journal-title":"Pharmacol. Rev."},{"key":"15707_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2012.07.010","author":"GV Kalayda","year":"2012","unstructured":"Kalayda, G. V., Wagner, C. H. & Jaehde, U. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells. J. Inorg. Biochem. https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.07.010 (2012).","journal-title":"J. Inorg. Biochem."},{"key":"15707_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1124\/mol.104.001198","volume":"66","author":"AK Holzer","year":"2004","unstructured":"Holzer, A. K. et al. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol 66, 817\u2013823. https:\/\/doi.org\/10.1124\/mol.104.001198 (2004).","journal-title":"Mol Pharmacol"},{"key":"15707_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc706","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M. et al. Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/nrc706 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"15707_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-175","author":"GV Kalayda","year":"2008","unstructured":"Kalayda, G. V., Wagner, C. H., Bu\u00df, I., Reedijk, J. & Jaehde, U. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. BMC Cancer https:\/\/doi.org\/10.1186\/1471-2407-8-175 (2008).","journal-title":"BMC Cancer"},{"key":"15707_CR13","doi-asserted-by":"publisher","DOI":"10.7150\/jca.19029","author":"S Zhu","year":"2017","unstructured":"Zhu, S., Shanbhag, V., Wang, Y., Lee, J. & Petris, M. A role for the ATP7A copper transporter in tumorigenesis and cisplatin resistance. J. Cancer https:\/\/doi.org\/10.7150\/jca.19029 (2017).","journal-title":"J. Cancer"},{"key":"15707_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"15707_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-023-00963-z","author":"M Demicco","year":"2024","unstructured":"Demicco, M. et al. Metabolic heterogeneity in cancer. Nat. Metabol. https:\/\/doi.org\/10.1038\/s42255-023-00963-z (2024).","journal-title":"Nat. Metabol."},{"key":"15707_CR16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.61.070192.005523","author":"D Wallace","year":"1992","unstructured":"Wallace, D. Diseases of the mitochondrial DNA. Ann. Rev. Biochem. https:\/\/doi.org\/10.1146\/annurev.bi.61.070192.005523 (1992).","journal-title":"Ann. Rev. Biochem."},{"key":"15707_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1058079","author":"T Pfeiffer","year":"2001","unstructured":"Pfeiffer, T., Schuster, S. & Bonhoeffer, S. Cooperation and competition in the evolution of ATP-producing pathways. Science (New York, NY) https:\/\/doi.org\/10.1126\/science.1058079 (2001).","journal-title":"Science (New York, NY)"},{"key":"15707_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-00504-8","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. https:\/\/doi.org\/10.1038\/s12276-020-00504-8 (2020).","journal-title":"Exp. Mol. Med."},{"key":"15707_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09206-0","author":"S Dar","year":"2017","unstructured":"Dar, S. et al. Bioenergetic adaptations in chemoresistant ovarian cancer cells. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-09206-0 (2017).","journal-title":"Sci. Rep."},{"key":"15707_CR20","doi-asserted-by":"publisher","first-page":"41637","DOI":"10.18632\/oncotarget.9317","volume":"7","author":"CD Hudson","year":"2016","unstructured":"Hudson, C. D. et al. Altered glutamine metabolism in platinum resistant ovarian cancer. Oncotarget 7, 41637\u201341649. https:\/\/doi.org\/10.18632\/oncotarget.9317 (2016).","journal-title":"Oncotarget"},{"key":"15707_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/msb.20134892","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol. Syst. Biol. https:\/\/doi.org\/10.1002\/msb.20134892 (2014).","journal-title":"Mol. Syst. Biol."},{"key":"15707_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07879-5","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Reprogramming of glutamine metabolism via glutamine synthetase silencing induces cisplatin resistance in A2780 ovarian cancer cells. BMC Cancer https:\/\/doi.org\/10.1186\/s12885-021-07879-5 (2021).","journal-title":"BMC Cancer"},{"key":"15707_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13048-024-01546-6","volume":"17","author":"MP Udumula","year":"2024","unstructured":"Udumula, M. P. et al. Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. J. Ovarian Res. 17, 226. https:\/\/doi.org\/10.1186\/s13048-024-01546-6 (2024).","journal-title":"J. Ovarian Res."},{"key":"15707_CR24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nu.15.070195.001025","author":"NP Curthoys","year":"1995","unstructured":"Curthoys, N. P. & Watford, M. Regulation of glutaminase activity and glutamine metabolism. Ann. Rev. Nutr. https:\/\/doi.org\/10.1146\/annurev.nu.15.070195.001025 (1995).","journal-title":"Ann. Rev. Nutr."},{"key":"15707_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)70403-1","author":"JD Klingman","year":"1958","unstructured":"Klingman, J. D. & Handler, P. Partial purification and properties of renal glutaminase. J. Biol. Chem. https:\/\/doi.org\/10.1016\/S0021-9258(18)70403-1 (1958).","journal-title":"J. Biol. Chem."},{"key":"15707_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0709747104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis, R. J. et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.0709747104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"15707_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 16, 749. https:\/\/doi.org\/10.1038\/nrc.2016.114 (2016).","journal-title":"Nat Rev Cancer"},{"key":"15707_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2009.06.025","author":"O Feron","year":"2009","unstructured":"Feron, O. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2009.06.025 (2009).","journal-title":"Radiother. Oncol."},{"key":"15707_CR29","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2002.6722","author":"R-Z Yang","year":"2002","unstructured":"Yang, R.-Z., Blaileanu, G., Hansen, B. C., Shuldiner, A. R. & Gong, D.-W. cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase. Genomics https:\/\/doi.org\/10.1006\/geno.2002.6722 (2002).","journal-title":"Genomics"},{"key":"15707_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0751-4","author":"M Kim","year":"2019","unstructured":"Kim, M. et al. Mitochondrial GPT2 plays a pivotal role in metabolic adaptation to the perturbation of mitochondrial glutamine metabolism. Oncogene https:\/\/doi.org\/10.1038\/s41388-019-0751-4 (2019).","journal-title":"Oncogene"},{"key":"15707_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33456","author":"D Mitra","year":"2021","unstructured":"Mitra, D. et al. Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. Int. J. Cancer https:\/\/doi.org\/10.1002\/ijc.33456 (2021).","journal-title":"Int. J. Cancer"},{"key":"15707_CR32","doi-asserted-by":"publisher","DOI":"10.7150\/thno.18992","author":"Y Cao","year":"2017","unstructured":"Cao, Y. et al. Glutamic pyruvate transaminase GPT2 promotes tumorigenesis of breast cancer cells by activating sonic hedgehog signaling. Theranostics https:\/\/doi.org\/10.7150\/thno.18992 (2017).","journal-title":"Theranostics"},{"key":"15707_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11971","author":"Y Hao","year":"2016","unstructured":"Hao, Y. et al. Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer. Nat. Commun. https:\/\/doi.org\/10.1038\/ncomms11971 (2016).","journal-title":"Nat. Commun."},{"key":"15707_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells11162597","author":"B Zhang","year":"2022","unstructured":"Zhang, B., Chen, Y., Bao, L. & Luo, W. GPT2 is induced by hypoxia-inducible factor (HIF)-2 and promotes glioblastoma growth. Cells https:\/\/doi.org\/10.3390\/cells11162597 (2022).","journal-title":"Cells"},{"key":"15707_CR35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0247","author":"MD Hall","year":"2014","unstructured":"Hall, M. D. et al. Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin and other platinum complexes. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0247 (2014).","journal-title":"Cancer Res."},{"key":"15707_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101272","author":"M Udumula","year":"2021","unstructured":"Udumula, M. et al. Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism - PubMed. Mol. Metabol. https:\/\/doi.org\/10.1016\/j.molmet.2021.101272 (2021).","journal-title":"Mol. Metabol."},{"key":"15707_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107839","author":"MP Udumula","year":"2023","unstructured":"Udumula, M. P. et al. Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response. iScience https:\/\/doi.org\/10.1016\/j.isci.2023.107839 (2023).","journal-title":"iScience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15707-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15707-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T08:19:55Z","timestamp":1755677995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15707-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15707"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15707-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6480518\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30528"}}